We offer cooperation to people of science who have already carried out their research projects aimed at creating a new drug to the point where the original idea has been verified in laboratory conditions and animal studies, and you can start preparing for the last two steps - says Adam Kruszewski, MD, CEO of Orphinic Scientific in an interview by Krzysztof Jakubiak, editor-in-chief of mZdrowie.pl.
It is about clinical trials that require completely different competences and negotiations with large pharmaceutical companies, where experience and business knowledge count. We help to perform clinical tests and bring a new drug or medical device to registration. In addition to using our know-how, we co-finance projects by taking shares in them.
